Is vaccination against human papillomavirus a possibility?
- 1 June 1998
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 351, S22-S24
- https://doi.org/10.1016/s0140-6736(98)90007-1
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- The Current Status of Therapeutic HPV VaccineAnnals of Medicine, 1996
- Dendritic Cells as Carriers for a Cytotoxic T-Lymphocyte Epitope-Based Peptide Vaccine in Protection Against a Human Papillomavirus Type 16-Induced TumorJournal of Immunotherapy, 1995
- Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide PerspectiveJNCI Journal of the National Cancer Institute, 1995
- Principles for Adoptive T Cell Therapy of Human Viral DiseasesAnnual Review of Immunology, 1995
- Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas.The Journal of Experimental Medicine, 1994
- Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cellsEuropean Journal of Immunology, 1993
- Prophylactic and therapeutic vaccination against a mucosal papillomavirusJournal of General Virology, 1993
- Detection of human serum antibodies that neutralize infectious human papillomavirus type 11 virionsJournal of General Virology, 1992
- Loss of MHC class‐I expression in cervical carcinomasInternational Journal of Cancer, 1990
- Morphological transformation in vivo of human uterine cervix with papillomavirus from condylomata acuminataNature, 1985